Volume 12, Number 2—February 2006
Dispatch
Arcobacter butzleri: Underestimated Enteropathogen
Valérie Prouzet-Mauléon*, Leila Labadi*, Nathalie Bouges*, Armelle Ménard†, and Francis Mégraud*
Table
Demographic and clinical characteristics of 19 patients infected with Arcobacter butzleri
| Patient* | Age (y) | Sex | Diarrhea | Abdominal pain | Blood in stool | Vomiting | Fever | General symptoms† | Duration of symptoms and disease course |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 88 | F | + | + | – | + | + | Death linked to associated neoplasia | |
| 2 | 75 | M | + | + | – | – | – | + | 4 days. Acute renal failure (treated with amoxicillin) |
| 4 | 89 | F | + | – | – | – | – | + | 6 weeks. Favorable progress after treatment with ofloxacin |
| 7 | 76 | M | + | + | + | – | – | – | 5 days (treated with ciprofloxacin) |
| 8 | 2 | M | + | – | – | + | – | + | 2 days |
| 10 | 69 | M | + | + | – | – | + | ||
| 11 | 4 | M | + | + | – | – | + | + | Several recurrences in 3 months |
| 12 | 72 | F | + | – | + | – | – | – | 3 weeks |
| 15 | 89 | M | + | – | – | ||||
| 18 | 53 | M | + | + | – | – | – | + | Irritable bowel syndrome |
| 19 | 6 | M | + | + | + | + | + | + | 10 days |
| 20 | 30 | F | – | + | – | – | – | – | |
| 21 | 68 | M | + | + | + | – | + | + | |
| 23 | 77 | M | + | – | + | Several days. Acute renal failure (treated with ciprofloxacin) | |||
| 25 | 1 | F | + | + | + | 3 weeks | |||
| 26 | 41 | M | + | – | – | – | – | + | Several days (treated with amoxicillin-clavulanate) |
| 27 | 44 | F | + | + | – | – | – | – | |
| 28 | 70 | F | + | ||||||
| 29 | 83 | F | + | + | – | – | – | + | Several days |
*All samples were from stool, except from patient 12, whose sample was blood.
†Anorexia, asthenia, weight loss.
Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.